Recorded on January 10, 2019

For many decades, treatment for AML remained stagnant. In recent years, new options have emerged. Join Dr. Ken Miller as he questions Dr. Alice Mims of The Ohio State University Comprehensive Cancer Center in Columbus, Ohio about these treatment updates. Dr. Mims also discusses how to tailor treatment to the patient’s goals of care, common mutations found in AML, and reviews the Beat AML® Master Trial.